$20 – $70

Healthcare Innovation Summit: Using Advanced Technologies for Personalized...

Event Information

Share this event

Date and Time

Location

Location

Marshall Student Center

4103 Cedar Circle

Room: MSC 2708

Tampa, FL 33620

View Map

Event description

Description



The Western Florida Chapter of the American College of Healthcare Executives presents the


WFC ACHE and the USF Healthcare Management Student Association (HMSA) are proud to present this all day event!

Please scroll down to review the agenda which includes several keynotes, meals, panels, networking, and Q & A's. We have also provided short bios for the speakers and included directions and maps for your convenience.

We look forward to seeing you at the USF Marshall Student Center September 27th for the ACHE WFC Healthcare Innovation Summit!


Agenda:

8:30 a.m. - 9:00 a.m.: Check-in, Networking, and Breakfast

9:30 a.m. - 10:15 a.m.: Telemedicine Keynote Speakers

- David Kirkus, Pharm.D., Director of Pharmacy Strategic Outreach/Walk-In Care Telehealth Services at Publix Supermarkets

- Ed Rafalski, Ph.D., MPH, FACHE, Senior Vice President, Chief Strategy & Marketing Officer at BayCare Health System

10:15 a.m. - 11:15 a.m.: Panel - Telemedicine in the Healthcare Delivery System

- Peter Chang, M.D., Vice President & Chief Medical Informatics Officer at Tampa General Hospital

- Thomas Ferrante, LL.M., J.D., M.B.A., Senior Counsel & Healthcare Attorney at Foley, & Lardner

- Deborah Ann Mulligan, M.D., FAAP, FACEP, Chief Medical Affairs Officer at MDLIVE

11:15 a.m. - 11:45 p.m.: Telemedicine Q & A Session

11:45 p.m. - 1:15 p.m.: Lunch Keynote - David Allard, Senior Healthcare Solution Executive at IBM Watson

1:15 p.m. - 2:00 p.m.: Precision Medicine Keynote Speaker

- Howard McLeod, Pharm.D., Medical Director, DeBartolo Family Personalized Medicine Institute at Moffitt Cancer Center

2:00 p.m. - 2:45 p.m.: Panel - The Promise & Perils of Precision Medicine

- Phillipa Greenberg, Chief Executive Officer at Next Machine

- Jennifer McCafferty-Fernandez, Ph.D., Director of Pediatric Research, Genomics, and Personalized Medicine at Nicklaus Children's Hospital

- Elizabeth Scarola, M.A, J.D., M.H.S.A., Healthcare Attorney at Carlton Fields

2:45 p.m. - 3:30 p.m.: Precision Medicine Q & A Session

3:30 p.m. - 4:00 p.m.: Closing and Networking

ACHE has awarded 3.0 Face-to-Face Education credits for this event for the panel sessions.

For the Lunch Keynote:

As an independent chartered chapter of the American College of Healthcare Executives, Western Florida Chapter is authorized to award 1.5 hours of ACHE Qualified Education credit toward advancement or recertification in the American College of Healthcare Executives.

Participants in this program who wish to have it considered for ACHE Qualified Education credit should list their attendance when they apply to the American College of Healthcare Executives for advancement or recertification.

Biographies:

Keynote Speakers:

Edward Rafalski, Ph.D., MPH, FACHE, Senior Vice President, Chief Strategy & Marketing Officer at BayCare Health System

Dr. Rafalski is responsible for all planning, business development, market research, marketing, web services, government relations, public relations and communications at BayCare Health System. Prior to BayCare, he was Senior Vice President of Strategic Planning & Marketing for Methodist Le Bonheur Healthcare, Memphis TN. Dr. Rafalski has an extensive background in strategic planning, data analytics, decision support, GIS, business development, marketing, public relations, group purchasing and managed care contracting. He has also served as an executive liaison for emergency department and children’s hospital operations. After graduating from the University of Chicago with a bachelor’s degree in public policy studies, Dr. Rafalski received a master’s degree in public health from Yale University School of Medicine. He received his Ph.D. in public health sciences from the Division of Health Policy and Administration at the University of Illinois, School of Public Health where he has taught as Clinical Assistant Professor. His health services research and teaching interests include: the effects of market economics on health care services, healthcare decision support, quantitative methods, managerial epidemiology health disparities, marketing and strategic management. Dr. Rafalski is a Fellow of the American College of Healthcare Executives, Six Sigma Black Belt and member of the 2014 TNCPE Board of Examiners, trained in the Baldrige Criteria for Performance Excellence. Ed is also a member of the University of South Florida College of Public Health's Master Health Administration Advisory Board.

David Kirkus, Pharm.D., Director of Pharmacy Strategic Outreach/Walk-In Care Telehealth Services at Publix Supermarkets

David Kirkus is Director of Pharmacy Administration at Publix Super Markets, a privately owned and operated Fortune 100 grocery chain with 2017 sales of $34.6 billion. Publix operates more than 1,100 stores in Florida, Georgia, Alabama, Tennessee, South Carolina, North Carolina and Virginia. Kirkus was named Director of Pharmacy Administration in 2018. In this role, he is responsible for managed care, procurement, technology, business development and strategy for more than 1,000 Publix Pharmacy locations, including eleven outpatient pharmacies located within hospitals in the state of Florida. Prior to his current role, Kirkus served as the Director of Pharmacy Strategic Outreach where he developed collaborations to bring innovative patient services into a retail pharmacy setting. In 2017, Kirkus spearheaded an agreement with BayCare Health System, leading to in-store telehealth kiosk services in 25 Publix Pharmacy locations within the greater Tampa Bay area. Kirkus received his Doctor of Pharmacy degree from University of Georgia, Athens, Georgia. He began working for Publix in 2002 as a Pharmacy Manager. In the past 16 years, he led several strategic initiatives resulting in revenue and net profit growth. Kirkus is passionate about finding new ways to meet patient needs while providing premier customer service and pharmaceutical care.

David Allard, Senior Healthcare Solution Executive at IBM Watson

With 20 years experience in providing healthcare and analytics solution to providers, payers and life sciences companies, Dave Allard now provides technical support to clients who are ready to address the world’s must pressing healthcare challenges with Watson Health technology. Dave is a domain expert versed in the data and processes involved in clinical care, operations, payment, and medical research. Prior to this current position, Dave provided strategic technical direction to Watson Health as their Chief Health Data Solution Architect. Before the formation of Watson Health Dave led IBM's Health Analytics Solution Center, providing solution architectures, proof of concepts and demonstrations of healthcare solutions to healthcare clients. Serving as IBM’s Chief Clinical Genomics Architect, he developed solutions and led high profile engagements at a number of academic medical research centers. Dave has been a proponent of open standards and participated for 5 years in HL7's Electronic Health Record (EHR) Technical Committee where he was one of the authoring group leads for the EHR functional standard. His innovative approaches have allowed him to accrue dozens of US and international patents.

Howard McLeod, Pharm.D., Medical Director, DeBartolo Family Personalized Medicine Institute at Moffitt Cancer Center

Dr Howard McLeod is Medical Director of the DeBartolo Family Personalized Medicine Institute at the Moffitt Cancer Center. He is chair of the Department of Individualized Cancer Management and a State of Florida Endowed Chair in Cancer Research. He is also a Senior Member of the Division of Population Sciences and Professor at the University of South Florida. Dr McLeod is chair of the NHGRI eMERGE network external scientific panel and a recent member of the FDA committee on Clinical Pharmacology and the NIH Human Genome Advisory Council. Since 2002, Dr McLeod has been vice chair for Pharmacogenomics for the major NCI clinical trials group, overseeing the largest oncology pharmacogenomics portfolio in the world. Dr McLeod is also a 1000 talent scholar of China and a Professor at Central South University in Changsha, China. Howard has published over 500 peer reviewed papers on pharmacogenomics, applied therapeutics, or clinical pharmacology and continues to work to advance individualized medicine.

Panelists:

Peter Chang, M.D., Vice President & Chief Medical Informatics Officer at Tampa General Hospital

Dr. Peter Chang is an award-winning Chief Medical Informatics Officer (CMIO) at Tampa General Hospital (TGH) in Tampa, Florida. Serving as Chief Medical Informatics Officer since 2014, Dr. Chang has been instrumental in developing and instituting THG’s quality governance structures process improvement efforts, and is currently overseeing the implantation of a GE Command Center at the Hospital. As an academic hospitalist, assistant professor and associate program director, all related to internal medicine, in addition to holding the CMIO role, Dr. Chang understands both the front-line clinician advantages of standardized processes and the work required to develop and measure those processes. In 2009, Dr. Chang was awarded the Intern of the Year in Internal Medicine and Humanism in Medicine Award, both from the University of South Florida Morsani College of Medicine. Dr. Chang was a multiple award winner again in 2011 as the State University System Minority Scholar as American College of Physicians Resident, as well as being named the Nathan L. Marcus award winner as the outstanding resident in Internal Medicine from Tampa General Hospital.

Thomas Ferrante, LL.M, J.D., M.B.A. Senior Counsel & Healthcare Attorney at Foley, & Lardner

Thomas (T.J.) Ferrante is senior counsel and a board certified healthcare lawyer with Foley & Lardner LLP, where he focuses his practice on telemedicine, telehealth, and virtual care, as well as a wide range of transactional and related regulatory issues for health industry clients. Mr. Ferrante works with hospitals, health systems, providers and startups to build telemedicine arrangements across the United States and internationally. He has experience with a variety of transactions, including mergers and acquisitions, joint ventures, strategic affiliations, obtaining and maintaining tax-exemption, employment contracts and leases, and other transactional matters. Mr. Ferrante also advises health care clients in all aspects of federal and state regulatory matters, including anti-kickback, self-referral laws, state licensure, fee splitting, Medicare and Medicaid reimbursement and compliance. In addition, Mr. Ferrante handles federal and state tax matters with respect to individual, corporate, tax exempt organization, and pass-through entities.

Deborah Ann Mulligan, M.D., FAAP, FACEP, Chief Medical Affairs Officer at MDLIVE

A tri-lingual, board-certified practicing pediatric emergency medicine physician Dr. Mulligan is the Founder and Director of the Institute for Child Health Policy at Nova Southeastern University (NSU) where she advises national health systems and policymakers about disruptive technologies and business models that accelerate transformation and constrain health expenditures. Dr. Mulligan is the Chief Medical Affairs Officer of MDLIVE, the nation’s leading provider of telehealth software and services. Dr. Mulligan has held leadership positions in health care, government, research and technology sectors to include that of Pediatric Services Medical Director for nation’s 4th largest safety net hospital system. She has served the Department of Health and Human Services MCHB EMSC as Project Director and Florida Senior Advisor of state model programs. Dr. Mulligan is active with her consultancy roles to the White House Office of National AIDS Policy, Center for Disease Control, and Florida State Agency for Health Care Administration and Department of Health. Dr. Mulligan serves on the University of California Santa Barbara Center for Digital Games Research Board of Advisors and Co-President/CMO to Sitio Saludable, Inc. a national multi-disciplinary media startup company formed to provide broadcast and digital content to promote and support positive health behavior change among the U.S. Hispanic population. Well published with over 100 peer review publications in her field, she has lectured globally and received numerous health policy, community service, scientific, educational and professional society awards, including recognition by the Honorable US Representative E. Clay Shaw in the US Congressional Record; National EMSC Heroes Award for Innovation; Florida Medical Association Physician Communicator of the Year; Florida State Surgeon General Injury Prevention Award. An NSU Professor of Pediatrics she received the Florida State University and Colleges ‘Campus COMPACT Community Engagement Educator Award’ presented by First Lady Michelle Obama. An award recipient of the International Health & Medical Media FREDDIE Award, she has extensive media experience in front and behind the camera. She is listed in IMDB for her contribution to Award Winning Indie Film “Tio Papi”; an American Academy of Pediatrics and American College of Emergency Medicine spokesperson featured on a broad media spectrum of bi-lingual radio, television, online and print such as The Today Show, GMA, Discovery Health Channel, Univision, Metro Networks, CNN en Español, Hispanic News Wire, The New York Times, the Wall Street Journal as well hosts a weekly radio segment on IHeartRadio’s WIOD. Dr. Mulligan serves as expert consultant and on-tour physician medical security advisor to entertainers on tour.

Phillipa Greenberg, Chief Executive Officer at Next Machine

Semi-Pro cyclist turned CEO, and Founder of Next Machine, a supercomputing firm which brings cluster computing and machine learning to the forefront. An early pioneer in commercializing computation, Phillipa Co-Founded a supercomputing app which provides a ‘Single Source of Truth’ for Distributed Computation. She joined an Alzheimer’s clinical research firm as Quality Assurance Director, overseeing the Regulatory/Biometrics & safety division for three years prior to making the transition to Bio-Pharma as a leader in Portfolio Bio-Asset Analytics, specializing in the oncology precision medicine analytics division. FIERCELY committed to sharing transformational systems and methodology and inspirational stories to audiences around the world, she remains a huge advocate for STEM & STEAM and women in science & tech initiatives. Next Machine is a full scope predictive analytics decision lab – We provide end-to-end solutions from: Infrastructure that supports big data initiatives to providing robust predictive/prescriptive outcome-driven data analysis, which will facilitate the acceleration of the most appropriate, personalized therapies for patients, quicker. Precision medicine is rapidly evolving and as we continue to leverage new genomic datasets and knowledge, Phillipa is committed to leveraging AI, machine learning and other forms of computation to address the outcomes, affordability and accessibility of precision medicine.

Jennifer McCafferty-Fernandez, Ph.D., Director of Pediatric Research, Genomics, and Personalized Medicine at Nicklaus Children's Hospital

Dr. McCafferty-Fernandez currently serves as the Director of the Nicklaus Children’s Research Institute & Office of Sponsored Programs where she is responsible for research infrastructure and compliance at Nicklaus Children’s Hospital and Nicklaus Children’s Health System (NCHS), including oversight of the AAHRPP-accredited human research protections program and clinical trial operations units. She is a Clinical Assistant Professor of Pediatrics at the Herbert Wertheim College of Medicine at Florida International University and Research Associate Professor of Medicine at the University of Miami Miller School of Medicine. In addition to her administrative duties, she leads the NCHS Personalized Medicine Initiative and serves as the Nicklaus Children’s Principal Investigator (PI) on the Sanford Children’s Genomic Medicine Consortium. She is also PI or Co-Investigator for several ongoing research studies including OneFlorida, a Patient Centered Outcomes Research Institute (PCORI) funded clinical data network. She is an alumna of the Graduate Research Ethics Education (GREE) program sponsored by the National Science Foundation and Indiana University and is a member of the Association for Practical and Professional Ethics (APPE), the Society for Corporate Compliance (SCCE), and the Healthcare Compliance Association (HCCA). She is active in the American Association of Medical Colleges (AAMC) compliance initiatives and was appointed to the Steering Committee for the Compliance Officers Forum (COF) in 2015. With certifications in healthcare compliance (CHC), research compliance (CHRC), privacy (CHPC) and corporate ethics (CCEP), Dr. McCafferty-Fernandez has served as an invited speaker for her expertise in cancer biology, career development, ethics as well as research and healthcare compliance issues. Dr. McCafferty-Fernandez lives in Miami, FL with her husband Mr. Rodolfo “Rudy” Fernandez and their four children.

Elizabeth Scarola, M.A, J.D., M.H.S.A., Healthcare Attorney at Carlton Fields

Elizabeth Scarola brings an insider’s perspective to her health care practice. In addition to her work on strategic, operational, and legal projects for a large, statewide clinically integrated network of hospitals and providers, she has hands-on scientific research experience. Ms. Scarola has conducted independent research in pediatric endocrinology and contributed to publications including Journal of the American Medical Association and the New England Journal of Medicine. Her background gives her a deep understanding of health policy, the Affordable Care Act, value-based reimbursement, population health, and translational research. Ms. Scarola enjoys helping health care clients navigate the complexity of implementing strategic and operational initiatives in today’s complex regulatory environment. She frequently advises hospital, provider, pharmaceutical, and medical device manufacturer clients on federal and state regulatory matters such as the Anti-Kickback Statute, self-referral laws, HIPAA compliance, and federal and private payor issues, including bundled payments, and risk-based contracting. She guides clients through strategic affiliations and transactions, including mergers, acquisitions, joint ventures, and contract negotiations. Additionally, she has extensive experience negotiating clinical trial agreements on behalf of hospitals, and has a keen personal interest in precision medicine initiatives. Prior to joining the firm, Ms. Scarola was an instructor for an undergraduate course on health care policy, medical ethics, patient safety, and the Affordable Care Act at the University of Michigan. She holds a Master in Medical Science degree from Boston University School of Medicine and a Master of Health Services Administration from the University of Michigan. Ms. Scarola is involved in a variety of volunteer initiatives. She is passionate about her work as a director of the non-profit Seeds of Hope for La Victoria, Inc., which provides medical assistance to residents of La Victoria, Dominican Republic. She has been involved with the organization since its founding, traveling to the area over 10 times, as well as leading others on medical mission trips to the region.


Maps & Directions:

Maps have been provided to guide you to both the parking lot and the event space. In addition to the images provided, text directions that will guide you directly to Lot 3B and the Marshall Student Center (MSC) are below. Please make note, once within the MSC, you must go to the second floor via stairs or elevators and then proceed to Room 2708 for the event.

Address:

Marshall Student Center at the University of South Florida - Room: MSC 2708

4103 Cedar Circle | Tampa, FL 33620

Please use Lot 3B off of USF Holly Drive for a 5 minute walk. Please see maps below. School will be in session, so please give yourself ample time to navigate the campus.

From I-275:

  1. Take exit 52, Fletcher Ave/CR-582A and head East for 2.5 miles.

  2. Turn right at USF Palm Dr.

  3. Turn left at USF Holly Dr. (Lot 3B will be after Laurel Drive on your right. There will be signs.)

  4. For those that do NOT need parking or are being dropped off, turn right at USF Cedar Circle.

From I-75:

  1. Take exit 266, Fletcher Ave and head West on Fletcher for 4.0 miles.

  2. Turn left at N Palm Dr/USF Palm Dr.

  3. Turn left at E Holly Dr. (Lot 3B will be after Laurel Drive on your right. There will be signs.)

  4. For those that do NOT need parking or are being dropped off, turn right at USF Cedar Circle.




Special THANKS to the USF Healthcare Management Student Association (HMSA) for teaming up with WFC ACHE to co-host the event, secure the space, and coordinate event details!


Share with friends

Date and Time

Location

Marshall Student Center

4103 Cedar Circle

Room: MSC 2708

Tampa, FL 33620

View Map

Save This Event

Event Saved